| Detected | Trial | Change |
|---|---|---|
| 2026-06-04 | NCT07618078 Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After… |
date change Primary completion pushed: 2028-12-31 -> 2031-12-31 |
| 2026-06-04 | NCT07618078 Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After… |
date change Completion pushed: 2028-12-31 -> 2031-12-31 |
| 2026-05-21 | NCT07590024 RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-01 | NCT07618078 Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After… | Recruiting | |
| 2026-05-15 | NCT07590024 RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma | Phase 3 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06964568 | CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC | Esophageal Carcinoma | Recruiting |
| NCT07590024 | RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma | Nasopharyngeal Carcinoma (NPC) | Recruiting |
| NCT07551479 | SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer | Locally Advanced Rectal Cancer (LARC) | Not Yet Recruiting |
| Phase 2 | |||
| NCT06281405 | CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced… | Locally Advanced Rectal Cancer | Recruiting |
| NCT07007182 | Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in… | Gastric Adenocarcinoma | Recruiting |
| NCT07432568 | A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in… | Intrahepatic Cholangiocarcinoma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07182565 | Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of… | Gastroesophageal Junction Adenocarcinoma | Recruiting |
| NCT06710847 | A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of… | Neoplasms, Colorectal | Active, Not Recruiting |
| Phase 1 | |||
| NCT05338775 | A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death… | Relapsed/ Refractory Multiple Myeloma | Active, Not Recruiting |
| Not specified | |||
| NCT07618078 | Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After… | Nasopharyngeal Carcinoma (NPC) | Recruiting |